Why Do Genetic and Lab Findings Often Mismatch in VTE Anticoagulant Defect Diagnosis?
Journal of Thrombosis and Haemostasis (JTH) shared an insightful post on LinkedIn:
“Genotype vs laboratory phenotype correlation of defects in natural anticoagulants in patients with venous thromboembolism.
In VTE patients, genotype-phenotype concordance for natural anticoagulant defects is far from absolute.
This study reveals that genetic variants may present with normal plasma activity, while reduced activity can occur without detectable variants – underscoring the diagnostic limitations of relying solely on either approach.”
Read the paper here.
Article: Genotype vs laboratory phenotype correlation of defects in natural anticoagulants in patients with venous thromboembolism
Authors: Christine Van Laer, Marthe Vanrenterghem, Marc Jacquemin, Andreas Verstraete, Sarissa Baert, Cyrielle Kint, Mirjam Kruijt, Renee Ruhaak, Veerle Labarque, Thomas Vanassche, Peter Verhamme, Kathelijne peerlinck, Kathleen Freson
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 12:46Rosa Hart: Inside Pediatric Stroke Recovery with Dr. Catherine Schuster
-
Apr 14, 2026, 12:39Gonzalo Ladreda: Innovation in Stroke Care Is About Timing, Integration, and Real-World Usability
-
Apr 14, 2026, 12:30Roy P.C. Kessels: Stroke’s Cognitive Impact on Young Adults Is Significant and Often Overlooked
-
Apr 14, 2026, 12:22Mehari Gebreyohanns: New Insights on Wake-Up Strokes from Emergency Settings in Texas and Louisiana
-
Apr 14, 2026, 12:08Enrico Ferro: Comparative Study Raises Questions on PFA Safety in AF at EHRA 2026
-
Apr 14, 2026, 11:39Prachi Patel: How B Vitamins and Large-Scale Research Are Shaping Stroke Prevention
-
Apr 14, 2026, 11:28Jamie Brannigan: Help Shape the Future of Brain-Computer Interfaces in Stroke and Neurological Care
-
Apr 14, 2026, 11:18David Ferri: A Fontan Conduit Thrombosis Managed With an Innovative Catheter-Based Thrombectomy
-
Apr 14, 2026, 09:51Understanding Bleeding Disorder of Unknown Cause – EHC